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The multidrug resistance gene 1 product, P-glycoprotein
(P-gp), is expressed in several excretory organs, including the
apical membrane of proximal tubules. After inducing acute
renal failure, P-gp expression is upregulated and this might
be a protective function by pumping out toxicants and
harmful products of oxidative stress. We characterized renal
function of P-gp knockout mice and studied its consequences
in renal ischemic damage. Compared with wild-type mice,
knockout mice have a lower glomerular filtration rate and
renal plasma flow. An augmented urinary excretion of
sodium, numerous amino acids, calcium, glucose, and low
molecular weight proteins was observed along with an
increased diuresis. A higher lithium plasma clearance in the
knockout mice suggested proximal tubular dysfunction.
Electron microscopy showed mitochondrial abnormalities in
proximal tubular cells that could account for decreased
adenosine triphosphate levels in the cortex. After inducing
ischemia, wild-type mice showed a decrease in creatinine
clearance and severe proximal tubular necrosis. In contrast,
knockout mice had no signs of tubular damage. Our data
indicate that P-gp knockout mice have impaired renal
function but are protected against ischemic renal injury.
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The multidrug resistant gene 1 (MDR1) product, P-glyco-
protein (P-gp), is a well-characterized adenosine triphosphate
(ATP)-dependent efflux transporter. The transport protein
was originally identified because of its overexpression in
tumor cells associated with an acquired cross-resistance to
various cytotoxic anticancer agents. However, further re-
search indicated that P-gp is also expressed in normal tissues,
like the intestine, liver, kidney, pancreas, blood-brain barrier,
and testis.1 The presence of P-gp in these excretory organs
and tissue barriers indicates that this transporter has an
important role in the protection of the organism against toxic
compounds. Indeed, studies in mice genetically deficient in
one of the P-gp genes, mdr1a, showed severe toxicity upon
exposure to ivermectine as a result of elevated drug levels in
many tissues, especially in brain, and decreased drug
elimination. Remarkably, these knockout mice have no
apparent phenotype under normal conditions.2
In the kidney, P-gp is localized to the apical membrane of
the proximal tubules where its exact function is at present
unknown, but given the demonstrated functions elsewhere in
the body and its substrate specificity, a role in the extrusion
of xenobiotics and metabolic wastes from blood into urine is
expected.3 The transporter is regulated through the activity of
hormones, protein kinases, and nuclear receptor signaling
pathways,4 however, the physiological regulation may be
influenced by exogenous factors, like exposure to (nephro-
)toxicants and cellular oxidative stress. We and others showed
an upregulation of the transport protein after ischemic–re-
perfusion damage5–7 or exposure to cadmium,8 in which
signalling of an nuclear factor-kB-dependent pathway might
be involved. The observed 4.7 times upregulation in P-gp in
the kidney after acute injury suggests that this transporter
possibly plays a role in the renal regeneration process.
The kidney has a high capacity to regenerate after injury.
In contrast to many other organs, the postischemic kidney
has the ability to restore its function and structure
completely.9 Regeneration of the tubular epithelial cells may
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result from dedifferentiation, cell division, and cell spreading
of neighboring viable tubular epithelial cells.9–11 Alternatively,
stem cells may be involved either residing within the kidney
or derived from circulating bone marrow.12–16 Studies by
Bunting et al.17,18 indicated that P-gp may function as a
regulator for stem cell differentiation. P-gp is highly
expressed on primitive hematopoietic stem cells and a
downregulation of this transporter triggers differentiation
of these progenitor cells. Whether P-gp is essential in
regeneration of the kidney after injury is unknown.
This study was designed to investigate the role of P-gp in
the kidney in more detail. We hypothesized that P-gp plays an
important role in proximal tubular physiology and in the
renal regeneration after ischemia–reperfusion injury. To test
this hypothesis, we extensively studied renal functional
parameters in mice lacking the expression of the two murine
homologs, mdr1a and mdr1b, the mdr1a/1b(/) mice. Further-
more, we studied the role of P-gp in renal regeneration after
ischemia–reperfusion injury. Our data indicate that mdr1a/
1b(/)mice have an impaired renal function caused by genera-
lized proximal tubular dysfunction. In addition, mdr1a/1b(/)
mice are protected against ischemic-renal damage.
RESULTS
Mdr1a/1b(/) mice show altered renal function parameters
After careful observation of the mdr1a/1b(/) mice, several
remarkable differences were seen (Table 1). Diuresis was
more than twofold increased in the knockout mice, after
collecting urine for 24 h (Po0.001). Mean arterial pressure
was increased compared to wild-type animals (Po0.05).
Furthermore, mdr1a/1b(/) mice showed elevated levels of
ureum in serum as compared with FVB (Friend leukemia
virus B strain) wild-type mice (Table 2). In contrast, serum
glucose and ionized calcium levels were significantly lower in
the knockout mice (Po0.01). All other parameters deter-
mined remained unchanged.
For the determination of urinary parameters, 24-h urine
was collected from mice maintained in metabolic cages
(n¼ 24, three mice per cage). Urinary sodium (Po0.05),
calcium (Po0.001), protein (Po0.001), and glucose
(Po0.01) excretion was significantly increased in the
knockout mice as compared with wild-type mice (Table 3).
Correcting the urinary values for creatinine excretion
revealed comparable results.
After placing mice on a low-sodium diet, we observed
comparable increasing sodium intake in both mice (Table 4),
but water intake was significantly higher in the mdr1a/1b(/)
mice. This increased water intake was accompanied by an
augmented urinary sodium excretion and loss of weight in
the mdr1a/1b(/) mice compared with FVB wild-type mice.
Plasma aldosterone levels were measured in pooled samples
of five mice, before and 7 days after placing the mice on a
low-sodium diet. In mdr1a/1b(/) mice, aldosterone levels
showed a twofold increase compared with basal levels in
Table 1 | General characteristics of mdr1a/1b(/) mice and wild-type FVB mice
Genotype Sex Age (weeks) Body weight (g) 24 h urine volume (ml) Kidney weight (mg) Mean arterial pressure (mm Hg)
FVB M 8 2472 0.7570.03 15273 7972
mdr1a/1b(/) M 9 2372 1.9070.11a 15677 9477b
Abbreviation: FVB, Friend leukemia virus B strain.
Phenotypic characterization of mdr1a/1b(/) mice revealed no changes in body weight and kidney weight. Diuresis was significantly increased in mdr1a/1b(/) mice, after
collecting 24-h urine obtained from mice maintained in metabolic cages (n=24), (three mice per cage). In addition, mean arterial blood pressure was significantly decreased
(n=9). Data are presented as mean7s.e.m.
aPo0.001 versus wild-type mice.
bPo0.05 versus wild-type mice.
Table 2 | Serum and blood gas analysis of FVB wild-type and
mdr1a/1b(/) mice
FVB wild type mdr1a/1b(/)
Creatinine (mmol/l) 3.470.3 3.870.2
Ureum (mmol/l) 6.070.1 7.670.5a
Sodium (mmol/l) 157.270.2 156.470.6
Albumin (g/l) 11.570.2 11.670.3
Lactate (mmol/l) 9.071.2 8.371.0
Glucose (mmol/l) 13.270.1 9.470.4b
Ionized Calcium (mmol/l) 1.2370.01 1.2070.01b
Potassium (mmol/l) 4.670.1 4.270.1
Base Excess (mmol/l) 8.972.0 6.371.1
HCO3 (mmol/l) 21.871.6 23.070.5
PCO2 (kPa) 9.370.4 8.770.6
pH 7.170.03 7.270.03
Abbreviation: FVB, Friend leukemia virus B strain.
Serum concentration of ureum was significantly increased in mdr1a/1b(/) mice
compared with wild type, in contrast to glucose and ionized calcium values, which
were decreased in mdr1a/1b(/) mice compared with FVB wild-type mice. Data are
presented as mean7s.e.m., n=24 mice.
aPo0.05 versus wild-type mice.
bPo0.01 versus wild-type mice.
Table 3 | Analysis of different compounds in urines from FVB
wild-type compared with mdr1a/1b(/) mice
FVB wild type mdr1a/1b(/)
Creatinine (mmol/24 h) 2.370.5 2.370.3
Ureum (mmol/24 h) 0.570.1 1.070.2
Sodium (mmol/24 h) 0.270.1 0.370.1a
Calcium (mmol/24 h) 0.870.1 3.870.4b
Protein (mg/24 h) 1.770.2 11.671.7b
Glucose (mg/24 h) 2.270.6 5.170.4c
Abbreviation: FVB, Friend leukemia virus B strain.
Urine was collected after housing 24 mice in groups of three in metabolic cages.
Excretion of sodium, calcium, proteins, and glucose were significantly increased in
mdr1a/1b(/) mice compared with wild-type mice. Urinary values were corrected
for diuresis and collecting time. Correction for creatinine excretion revealed similar
results.
aPo0.05 versus control.
bPo0.001 versus control.
cPo0.01 versus control.
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contrast to FVB wild-type mice, in which levels remained
unchanged (Table 4). This points to extracellular volume
contraction in mdr1a/1b(/) mice.
To investigate the renal function in mdr1a/1b(/)mice in
more detail, we determined the glomerular filtration rate
(GFR) and renal plasma flow (RPF) by the clearances of
[3H]-inuline and [14C]-para-aminohippuric acid (PAH),
respectively. In mdr1a/1b(/) mice, GFR was significantly
decreased (Po0.01) compared with wild-type mice. RPF was
decreased in mdr1a/1b(/) mice (Po0.05; Figure 1) as well.
Proximal tubular function is disturbed in mdr1a/1b(/) mice
The proximal tubular cells are responsible for the reabsorp-
tion of the majority of the filtered water and electrolytes in
the kidney and excretion of metabolic wastes. Moreover,
tubular cells are involved in the reabsorption of a large
amount of essential compounds, for instance glucose,
phosphate, calcium, uric acid, and amino acids. The
increased urinary excretion of sodium, calcium, proteins,
and glucose may reflect a disturbed proximal tubular
function. To investigate the reabsorptive function of the
proximal tubule, we studied lithium plasma clearance after a
single subcutaneous injection of lithium chloride (10 mmol/kg
bodyweight). One hour after the injection, plasma concen-
trations of lithium were at maximum and did not differ
between both mice (Figure 2). However, 3, 6, and 8 h after
injection, the decline in the lithium concentration curve was
faster in the knockout mice as compared with the wild-type
mice, indicating that lithium plasma clearance was signifi-
cantly higher in mdr1a/1b(/) as compared with FVB wild-
type mice (13.370.2 versus 8.570.1 ml/min, Po0.001).
Under normal conditions, lithium is highly reabsorbed by
the proximal tubules and a reduction in lithium reabsorption
points at a disturbed proximal tubular function.
Furthermore, we investigated the amount and pattern of
proteins excreted in urine by gel electrophoresis. Bovine
serum albumin (BSA) was used as an internal control at two
concentrations (Figure 3). Gels were loaded with 25 ml of
urine collected from FVB wild-type and mdr1a/1b(/) mice.
Both mice showed an equivalent urinary albumin excretion,
but low molecular weight protein levels were abundantly
present in urines from mdr1a/1b(/) mice but not from
wild-type mice. This confirms the proximal tubular reab-
sorption dysfunction in the knockout mice.
Most proteins filtered by the glomerular apparatus are
reabsorbed by endocytosis in the proximal tubules, a process
in which the transmembrane receptor protein megalin is
involved. Megalin is a cell surface receptor localized in the
brush border membrane of the proximal tubules. Here, it
mediates the tubular reabsorption of various filtered proteins,
Table 4 | Analysis of food- and water intake, weight loss and diuresis in FVB wild-type mice and mdr1a/1b(/) mice receiving a
diet with a low-sodium content
FVB wild type mdr1a/1b(/)
Days after low sodium diet 0 2 7 0 2 7
Sodium intake (mg/day) 1.771.5 1.270.2 1.170.3 6.174.1 1.070.4 1.070.7
Water intake (g/day) 1.470.2 1.970.6 1.770.4 2.770.9a 4.270.8b 3.070.6b
Weight loss (% of day 0) — 8.173.1 4.272.2 — 10.573.9b 15.971.9c
Creatinine clearance (ml/min) 474717 463718 479712 424719 358715b 296720c
Urinary sodium excretion (mmol/day) 0.270.1 0.270.2 0.270.1 0.370.1 0.870.2b 0.470.1b
Plasma aldosterone (nmol/l) 0.42 0.53 0.38 0.80
Abbreviation: FVB, Friend leukemia virus B strain.
Food and water intake was measured after housing mice individually in metabolic cages. Food intake was increased in both mice after switching to a low sodium diet. Water
intake, weight loss, creatinine clearance, and urinary sodium excretion were significantly different in mdr1a/1b(/) mice after changing diet contents. Additionally,
aldosterone levels increased in mdr1a/1b(/) mice 7 days after changing diet contents. Data were obtained from five FVB and five mdr1a/1b(/) mice, aldosterone values
were determined in blood from five pooled mice.
aPo0.05 versus FVB wild type on day 0.
bPo0.01.
cPo0.001 versus wild-type levels at the same time point after changing diet contents.
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Figure 1 | Renal hemodynamics in FVB wild-type mice and mdr1a/
1b(/) mice. Mdr1a/1b(/) mice show a decreased GFR (a) and RPF
(b) compared with FVB wild-type mice. GFR and RPF were measured
using [3H]-inulin and [14C]-PAH clearances, respectively. Data are
expressed as mean7s.e.m. of six mice. Significantly different from
FVB wild-type mice (*Po0.05; **Po0.01).
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like b2-microglobulin and immunoglobulin light chains.
19–21
Figure 4 shows a clear positive immunostaining of megalin
and normal brush border composition, indicating that the
differences in protein handling between both mice are not
explained by alterations in megalin expression.
In addition, the urinary excretion of free amino acids in
mdr1a/1b(/) mice was compared to the excretion in wild-
type mice. Figure 5 presents an overview of the calculated
tubular reabsorption of 23 different compounds. The tubular
reabsorption of glutamine, proline, phenylalanine, ornithine,
and arginine was severely decreased in mdr1a/1b(/) mice
compared with FVB wild-type mice.
Finally, the proximal tubules were examined morpholo-
gically with electron microscopy. Representative images show
mitochondrial adaptations in the mdr1a/1b(/) mice
compared with the FVB wild-type mice: mitochondria were
swollen, and cristae morphology was altered (Figure 6b and
c). Other abnormalities were not observed: the brush border
membrane appears to be intact as is the glomerular
apparatus. Mitochondrial adaptations in mdr1a/1b(/) mice
were accompanied by a 50% reduction in ATP compared
with FVB wild-type mice (Figure 6d).
Mdr1a/1b(/) mice are less sensitive to ischemic reperfusion
damage
To study the role of P-gp in renal regeneration, we induced
acute tubular necrosis in FVB wild-type and mdr1a/1b(/)
mice. In agreement with our previous study,5 a significantly
decreased creatinine clearance was observed in wild-type FVB
mice 2 days after ischemia induction (Po0.001). Renal
function recovered partially 7 days after ischemia as
compared with the normal baseline creatinine clearance in
sham-operated mice. In contrast, mdr1a/1b(/) mice only
showed a slight decrease in creatinine clearance (not
significant) 2 days after inducing ischemia, which remained
unchanged until 7 days after ischemia (Figure 7). A
significant difference in creatinine clearance between wild-
type and the knockout mice was observed 2 days after
inducing ischemia (Po0.01). Histological examination 2
days after inducing renal ischemia confirmed unaltered renal
function in mdr1a/1b(/) mice, whereas serious damage is
observed in the FVB wild-type mice (Figure 8).
To investigate the mechanism of protection in more detail,
we isolated bone marrow cells from FVB wild-type and
mdr1a/1b(/) mice and studied the level of apoptosis. After
exposure of cells for 12 h to 1 mM H2O2, we found that 16%
of cells from wild-type mice were early apoptotic and 34%
late apoptotic (Figure 9a). Cells from mdr1a/1b(/) mice
show significantly less sensitivity to the apoptosis trigger
(13% of the cells is early and 9% late apoptotic, Figure 9b).
DISCUSSION
P-gp plays a key role in excretory organs, like intestine, liver,
and possibly also kidney, where it exports xenobiotics and
waste products out of the cell lowering their intracellular
concentration.3 Variable P-gp expression levels due to genetic
diversity influences the absorption and excretion of P-gp
substrates resulting in an altered drug response.22 The
absence of mdr1a and mdr1b in knockout mice appears to
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Figure 2 | Time course of lithium plasma concentrations after
injecting 10 mmol/kg bodyweight lithium chloride in FVB wild-
type mice and mdr1a/1b(/) mice. Lithium plasma clearance is
significantly decreased in mdr1a/1b(/) mice (&), in time compared
with FVB wild-type mice (’; 8.570.1 versus 13.370.2 mmol/l,
Po0.001). Data are measured in 16 mice, divided in four groups and
presented as mean7s.e.m. Significantly different from FVB wild-type
mice (***Po0.001).
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Figure 3 | Representative gel showing the amount and pattern
of urinary proteins. Representative images of urine samples
separated on a 10% polyacrylamide gel. Urine from mdr1a/1b(/)
mice show an increased excretion of low molecular weight proteins
compared with FVB wild-type mice, corrected for albumin excretion.
(a) Urine (25ml) from FVB (lane 3) and mdr1a/1b(/) (lane 4) was used
to determine protein patterns by gel electrophoresis. BSA (lane 1 and
2) was used as a control, in two different concentrations, 1.3 and
0.65mg, respectively. (b) Semiquantification of gels by measurement
of pixel intensities (arbitrary units). Values are means7s.e.m., n¼ 5.
Significantly different from wild-type FVB mice (***Po0.001).
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lead to increased sensitivity to toxicants.23 In addition,
mdr1a(/) mice maintained under specific pathogen-free
conditions developed spontaneous colitis.24 In this study, we
showed that in addition to these characteristics, mdr1a/1b(/)
mice suffer from generalized proximal tubular dysfunction.
Furthermore, we showed that mdr1a/1b(/) mice were
resistant to ischemic damage.
In comparison with wild-type mice, the knockout mice
showed a twofold increased diuresis and a loss of sodium, low
molecular weight proteins, glucose, and calcium in the urine.
This increased urinary sodium excretion was not caused by
an increased ingestion, which can be concluded after
performing an experiment with a low-sodium diet for 1
week. The increased water intake, weight loss, and decreased
creatinine clearance point at a renal problem in the mdr1a/
1b(/) mice. No significant reduction in basal creatinine
clearance was observed as compared with wild-type mice,
although GFR, measured by inulin clearance, was found to be
reduced. This discrepancy might be attributed to the
differences in proximal tubular secretion of creatinine.
Another possible explanation is that the inulin clearance
measurement was performed under isoflurane anesthesia,
which gives a fall in blood pressure leading to a temporarily
decreased filtration rate as a consequence of lower glomerular
pressure. The effect might be more pronounced in mdr1a/
1b(/) mice as compared with the wild-type mice. This view
is in line with the reduced RPF as found by the PAH
clearance, which may, however, also be explained by the
proximal tubular dysfunction in these mice. Slightly elevated
blood pressure observed in conscious mdr1a/1b(/) mice
compared with wild type mice is surprising in the view of
increased sodium and water excretion, but might be a
consequence of the loss of kidney function in the knockout
mice. Hence, this deserves further investigation. The
increased plasma lithium clearance pinpoints at a proximal
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Figure 4 | Megalin expression in wild-type mice and in mdr1a/1b(/) mice. Representative immunohistochemical images show that
megalin is expressed in the apical membrane of the proximal tubules in wild-type mice (a) and mdr1a/1b(/) mice (b). Green counterstaining
indicates Naþ /Kþ -ATPase expression. Arrows point to megalin staining in the apical membrane of the proximal tubules. DT¼distal tubule.
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Figure 5 | Fractional tubular reabsorption of free amino acids in
mdr1a/1b(/) mice compared with FVB wild-type mice.
Percentage of the amino acids that are reabsorbed in the proximal
tubule. A decreased tubular reabsorption of several free amino acids
is seen in mdr1a/1b(/) mice (&), compared with wild-type
mice (’). Data are measured in four pooled samples from eight mice
each, given as a mean7s.e.m.
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Figure 6 | Mitochondrial morphology of mdr1a/1b(/) mice
compared FVB controls. (b and c) Mdr1a/1b(/) mice show
mitochondrial adaptations as compared to (a) wild-type FVB mice.
(d) These abnormalities are accompanied by decreased ATP levels in
kidney cortex. N, nucleus; BB, Brush Border membrane; L, tubulary
lumen; M, mitochondria; BL, basolateral membrane. Data are
measured in three pooled samples from 12 mice each, given as a
mean7s.e.m. (**Po0.01). ((a and b) Original magnification 2000
(c) Original magnification 10 000).
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tubular defect. In addition, tubular reabsorption of amino
acids and low molecular weight proteins was decreased and
confirms generalized proximal tubular dysfunction or, so-
called, renal Fanconi syndrome. Most apical proximal tubular
transport is coupled to sodium and requires a transmem-
brane electrochemical gradient, established by the basolat-
erally expressed Naþ /Kþ -ATPase. Less fuel for Naþ /Kþ -
ATP-ase due to intracellular ATP depletion is postulated to
cause renal Fanconi syndrome in humans with mitochondrial
disorders25 and cystinosis.26,27 Strikingly, decreased intracel-
lular ATP levels and impaired mitochondrial morphology
were observed in the mdr1a/1b(/) mice, suggesting that
disturbed energy metabolism is responsible for the develop-
ment of generalized proximal tubular dysfunction observed
in our model.
The role of mdr1/MDR1 in this process is speculative, but
the localization of the gene product, P-gp, in excretory organs
indicates that an absence of this transporter may lead to
barrier dysfunction, which is also observed in mdr1a(/)
mice developing colitis.24,28 Under normal circumstances,
waste products and xenobiotics are excreted in the urine,
however, the absence of P-gp may lead to accumulation of
these potentially toxic products. Subsequently, mitochondrial
function may be impaired and, as a consequence, generalized
proximal tubular dysfunction will be developed. Future
research will be directed to solve this issue.
Mdr1a/1b(/) mice are frequently used in pharmacolo-
gical studies to investigate the in vivo role of P-gp in drug
excretion. For drugs excreted primarily via the kidney, like
digoxin, however, the reduced renal function of the knockout
mice, as observed in this study, might have a great influence
on their pharmacokinetics. Despite an upregulation of mdr1b
P-gp in the kidney in mdr1a(/) mice,2 the in vivo
pharmacokinetics and tissue distribution of digoxin were
strongly affected.29 These effects may not have been
PTC PTC
Figure 8 | Histopathology of the mouse kidney after inducing ischemia. Characteristic histologic signs of renal injury and regeneration
after an ischemic insult in (a–c) FVB wild-type mice and (d–f) mdr1a/1b(/) mice. (a) Control kidney slices from FVB wild-type mice showing
a proximal tubule (PTC). Intact brush border membranes are indicated by arrows. (b) Two days after bilateral clamping of the renal artery
and vein from 30 min, serious damage to the PTC is observed with debris in tubular lumen (indicated by arrows) and destroyed brush
border membranes. (c) Seven days after the insult the tubules are partially recovered as can be concluded from repaired brush border
membranes (indicated by arrows). (d) Control kidney slice from mdr1a/1b(/) mice. (e) Two days after the ischemic insult, no histological
changes are seen in the knockouts. Brush border membranes are still intact (indicated with arrows) and there is no debris observed in
the tubular lumen. (f) Seven days after ischemia still no abnormalities were observed. (Original magnification 400).
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Figure 7 | Effects of renal ischemia–reperfusion on renal
function in mdr1a/1b(/) mice compared with FVB wild type. FVB
wild-type (’) mice show a normal reaction to an ischemic insult:
creatinine clearance decreased after 2 days and increased
to baseline values after 7 days. In contrast, mdr1a/1b(/) mice (&)
showed no changes in creatinine clearance 2 and 7 days after
inducing ischemia. Data are expressed as mean7s.e.m. of six
mice. Significantly different from FVB wild-type mice (***Po0.001).
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influenced solely by the absence of mdr1a, but a decrease in
GFR might have contributed to the outspoken pharmacolo-
gical effects, although renal function in the single knockout,
mdr1a(/) mice, has not been determined. Clearly, a
reduction in renal function in combination with an absence
of P-gp results in elevated plasma levels of drugs that are
substrates for P-gp and/or excreted by the kidney, which
might lead to toxicity.
In addition to the proximal tubular dysfunction, the
knockout mice show resistance against ischemia/reperfusion
injury, as determined by histological staining and the
clearance of creatinine. This was unexpected, because we
previously observed an upregulation in P-gp expression after
inducing ischemia–reperfusion injury,5 suggesting a protec-
tive role of the drug efflux pump in renal damage. P-gp has
the ability to inhibit Fas-induced apoptosis,30,31 and the high
expression of P-gp on primitive stem cells indirectly suggests
that absence of P-gp would disturb renal regeneration after
an ischemic insult.18 Therefore, we expected more severe
tissue damage after ischemia–reperfusion and less ability to
restore the tissue. To rule out a protective effect of volume
expansion,32,33 serum aldosterone levels were measured and
were found to be comparable in both mice in basal situations.
After a low-sodium diet for 1 week, however, increased
plasma aldosterone concentrations were observed in the
mdr1a/1b(/) mice. This indicates that the renin-angiotensin
aldosterone system (RAAS) is activated to compensate for the
loss of sodium in urine and to protect against the
accompanying volume depletion. Alternatively, cells derived
from mdr1a/1b(/) mice and FVB wild-type mice were
exposed to the apoptotic trigger H2O2. We found decreased
levels of apoptosis in the cells deficient in P-gp. This
observation suggests that the smaller degree of renal damage
in mdr1a/1b(/) mice kidneys after ischemia might be
caused by a decreased number of apoptotic cells causing
tubular obstruction. Evidently, the role of P-gp in this process
needs to be investigated further.
In conclusion, the results of this study indicate that
decreased intracellular ATP levels and impaired mitochon-
drial morphology may be responsible for the generalized
proximal tubular dysfunction observed in mdr1a/1b(/)
mice. The protection against ischemic damage might be the
consequence of ischemic preconditioning, but more research
is needed to investigate the exact role of P-gp in this model.
MATERIALS AND METHODS
Materials
Hank’s-balanced salt solution (HBSS) was purchased from Gib-
coBRL (Breda, The Netherlands). [methoxy-3H]-inulin (inulin) was
obtained from Amersham Pharmacia Biotech UK Ltd. (Buckin-
ghamshire, UK) and [14C]-PAH was from NEN Life Science.
a-Chloralose–HBC complex (1,2-O-(2,2,2-Trichloroethylidene)-
a-D-glucofuranose: 2-hydroxypropyl-b-cyclodextrin complex was
obtained from Sigma (St Louis, MO, USA) and dissolved in a
physiological salt solution at a concentration of 0.16 g/ml. All other
chemicals were of analytical grade and purchased from Sigma.
Animals
The animal ethics board of the Radboud University Nijmegen
Medical Centre approved all experimental procedures. Male FVB
mice (6–8 weeks) were obtained from Charles River (Sulzfeld,
Germany), and were housed under routine laboratory conditions at
the Central Animal Facility Nijmegen. Mdr1a/1b(/) mice (6–8
weeks, with an FVB background) were kindly provided by the group
of Dr Alfred Schinkel,34 but were bred and housed in Nijmegen.
Embryo transfer was performed with mdr1a/1b(/) mice to create
identical microbiological conditions. To test the genetic background,
we performed quantitative real-time polymerase chain reaction on
three different housekeeping genes, as described in Huls et al.5 No
differences in raw CT values were observed between FVB and mdr1a/
1b(/) mice (glyseraldehyde-3-phosphate dehydrogenase: FVB
19.770.1, mdr1a/1b(/) 19.770.2; 18S rRNA internal control:
FVB 13.770.2, mdr1a/1b(/) 13.670.3, glucoronidase: FVB
25.670.4, mdr1a/1b(/) 26.470.6). For collection of urine, eight
groups of three mice were housed in metabolic cages (Techniplast,
Exton, PA, USA). Mice were allowed to adapt to these cages for
1 day, whereafter 24-h urine samples were collected. Mice were
injected intraperitoneally 0.5 ml of 0.9% NaCl (B Braun Melsungen
AG, Melsungen, Germany) in order to maintain a normal fluid
balance. Food and water were available ad libitum. Urine was partly
frozen at 201C or freshly analyzed for basic urinary parameters
and amino acids, performed by routine laboratory tests. Blood was
collected via retro-orbital punction and basic blood parameters were
determined.
For the measurement of food intake, water intake, weight loss,
and aldosterone, we placed wild-type and mdr1a/1b(/) mice on a
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Figure 9 | Bone marrow cells from mdr1a/1b(/) mice show
less sensitivity to apoptosis trigger. Representative picture (N¼ 6)
of early (lower right) and late apoptotic (upper right) bone marrow
cells from (a and c) FVB wild-type and (b and d) mdr1a/1b(/)
mice. (a) In untreated bone marrow-derived cells from FVB mice, 7%
of the cells are early apoptotic and 0% of the cells were late
apoptotic. (b) In healthy mdr1a/1b(/) mice, 4% is early apoptotic
compared with 0% in the late apoptotic phase. (c) After inducing
apoptosis using 1 mM H2O2, 34% of the cells gated were late
apoptotic and 16% was early apoptotic in FVB wild-type mice.
(d) In mdr1a/1b(/) mice, 9% of the cells gated were late apoptotic
and 13% of the cells were early apoptotic.
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diet with low-sodium content (Ssniff EF R/M, Na, Soest, Germany).
Mice were housed individually in metabolic cages for 7 days, where
they received sodium low diet and water ad libitum. Food intake,
water intake, diuresis, and weight were measured every day.
Aldosterone levels were measured after extraction and paper
chromatography as described,35 before and 7 days after diet
modification in pooled blood samples.
Renal function assessment
FVB wild-type and mdr1a/1b(/) knockout mice were anesthetized
with isoflurane (3% v/v) and placed on a servo-controlled surgical
table that maintained body temperature at 371C, measured rectally.
Animals were allowed to breath air by placing a plastic chamber over
the nose into which either isoflurane (2% v/v), O2 (250 ml/min) and
N2O (50–100 ml/min) were continuously passed or O2 (250 ml/min)
and N2O (50–100 ml/min) together with intra-arterial infused a-
chloralose (0.26 ml divided over three dosages during experimental
time) for anesthesia. The right carotid artery was canulated with PE-
10 tubing connected to PE-50 tubing for administration of a-
chloralose and blood sampling. The bladder was catheterized with a
PE-50 tube to the urethra after which the bladder was ligatured.
Urine samples were collected continuously. The right jugular vein
was catheterized with PE-10 tubing for fluid infusion. During
surgery and the stabilization period, a Hank’s-balanced salt solution
solution supplemented with 10 mM HEPES (N-2-hydroxyethylpi-
perazine N0-2-ethanesulfonic acid) at pH 7.4 was infused at a rate of
4.2ml/min. After the stabilization period (45 min), intravenous
infusion was changed to Hank’s-balanced salt solution-HEPES
containing inulin (5 mCi/ml) and PAH (1mCi/ml) and infused at a
rate of 25 ml/min during the first 5 min to achieve steady-state,
whereafter infusion rate was set back to 4.2 ml/min. Three
consecutive 30-min urine collections were obtained and blood
samples (50 ml) were drawn at 30, 60, and 90 min in heparinized
glass capillaries. After 90 min, mice were killed. Radioactive
[methoxy-3H]-inulin and [14C]-PAH in blood and urine was
measured in a liquid scintillation counter to determine inulin and
PAH. Inulin clearance, a marker for GFR, was calculated as Uv
Uc/Pc. Where Uv is the urine volume, Uc is the urine concentration
of inulin and Pc is the plasma concentration of inulin. PAH
clearance is a marker RPF, and was calculated similarly to the inulin
clearance.
Blood pressure measurements
After 7 days of acclimation in our animal facilities, mean arterial
pressure was measured in conscious mice (n¼ 6 per group) using
the ‘Non Invasive Blood Pressure Monitor’ (Columbus Instruments,
OH, USA), as described.36
Lithium plasma clearance
To characterize proximal tubular function, we injected 16 mice
subcutaneously with 10 mmol/kg of lithium chloride (Merck,
Darmstadt, Germany). After collecting blood from all mice before
injection, mice were divided in groups of four and blood was
collected 1, 3, 6, and 8 h after injection. Lithium concentrations were
determined in serum according to the method described by Tabata
et al.37
Ischemia induction
FVB wild-type and mdr1a/1b(/) mice were anesthesized with
isoflurane and ischemia was induced by bilateral clamping of renal
arteries and veins for 30 min; control mice were sham operated.
Mice were placed in metabolic cages 2, 7, and 14 days after inducing
ischemia to collect urine and blood. Mice were killed by
exsanguination. Kidneys were removed and fixed in Bouin’s
solution. Serum and urinary creatinine levels were measured by
high-performance liquid chromatograph.38
Detection and specification of proteins by electrophoresis
The amount and pattern of proteins in the urine samples were
determined by gel electrophoresis. Samples were corrected for
differences in diuresis, fractionated, and loaded on a 10% SDS
polyacrylamide gel. Two different concentrations of BSA (Sigma
Aldrich, Zwijndrecht, The Netherlands) were used to determine the
amount of protein semiquantitatively. After electrophoresis, the gels
were rinsed three times for 5 min with ultrapure water and
subsequently stained for 1 h with Gelcode blue stain reagent (Pierce,
Rockford, IL, USA). Finally, to enhance stain sensitivity, the gels
were destained for at least 1 h with ultrapure water.
Electron microscopy, immunofluorescence, and light micro-
scopy
For electron microscopy, small pieces of cortex were fixed in 2.5%
glutaraldehyde dissolved in 0.1 mol/l sodium cacodylate buffer (pH
7.4, for 24 h at 41C), and washed in the same buffer.39 Tissue
fragments were post-fixed in cacodylate buffered 1% OsO4 for 1 h,
dehydrated and embedded in Epon 812 (Merck, Darmstadt,
Germany). Ultrathin sections were cut using an ultratome (LKB
instruments, Bromma, Sweden) and stained with 4% uranyl acetate
for 45 min and with lead citrate for 2 min at room temperature.
Sections were examined using an electron microscope (JEOL 1200
EX2, Tokyo, Japan).
For immunohistochemistry, kidney fragments were snap frozen
in liquid nitrogen, and 2 mm cryostat sections were used. Sections
were fixed in acetone for 10 min and air-dried. Subsequently, slices
were incubated with the primary monoclonal antibody against
megalin, dilution 1:100 (antibody 1H2 was a kind gift from WS
Argraves;40) in phosphate-buffered saline, 0.5% BSA for 1 h at room
temperature. Counterstaining was performed with an antibody
directed against Naþ /Kþ -ATP-ase 41 diluted 1:1000. Next, slices
were washed three times with phosphate-buffered saline and
incubated with the secondary antibody; goat anti-rabbit Alexa Fluo
488 was used for Naþ /Kþ -ATP-ase and goat anti-mouse Alexa
Fluor 594 for megalin (Invitrogen, Breda, The Netherlands) diluted
1:200. Sections were examined using a fluorescence microscope
(Leica lasertechnik GmbH, Heidelberg, Germany).
For light microscopy, kidney fragments taken 2, 7, and 14 days
after inducing ischemia were fixed in Bouin’s solution, dehydrated,
and embedded in paraplast (Amsterstad, Amsterdam, The Nether-
lands). Sections of 3 mm were stained with periodic acid-Schiff.
Measurement of total intracellular ATP
Mouse kidney cortex was homogenized in ice-cold isolation buffer
(300 mM mannitol, 10 mM HEPES, 1 mM EGTA, 0.1% BSA, pH 7.4)
by hand in a Potter-Elvehjem homogenizer with Teflon Pestle
(Braun, Melsungen, Germany). After washing in phosphate-buffered
saline, the homogenate was shock frozen in liquid nitrogen and
stored at 801C until determination. Before ATP determination, the
homogenate was resuspended on ice in 0.5 ml cold phosphate-
buffered saline. A 25-fold diluted fraction (25 ml) of the suspension
was transferred to a white microtiter plate and ATP was measured
using ATP Bioluminescence Assay Kit HSII (Roche, Basel, Switzer-
land) as described by Levtchenko et al.27 according to the
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instructions of the manufacturer. The residue of the undiluted cell
suspension was used for protein determination using the Lowry’s
method.
Bone marrow cell isolation and apoptosis measurements
Bone marrow cells were harvested by flushing tibiae with Iscove’s
Modified Dulbecco’s Medium (Invitrogen, Breda, The Netherlands)
containing 1% Penicilline Streptavidine and 0.1mM beta mercap-
toethanol. Cells were seeded in six-well plates and exposed to 1 mM
of H2O2 for 12 h. Subsequently, cells were harvested and apoptosis
was stained using an Annexin V-FITC Apoptosis Detection Kit
(BioVision Research Products, CA, USA), whereafter cells were
analyzed using a cell sorter (FACScan analyzer (Becton Dickinson,
Oxnard, CA, USA)).
Data analysis
Data are given as means7s.e.m. Mean values were considered to be
significant when Po0.05 by use of a Student’s t-test. Software used
for statistical analysis was Graphpad Prisms (version 4.03 for
Windows; Graphpad Software, San Diego, CA, USA).
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